Search the Journal

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Temporal Artery Biopsy for Giant Cell Arteritis

REGINA TAYLOR-GJEVRE, MINH VO, DINO SHUKLA, and LOTHAR RESCH

ABSTRACT.

Objective. To evaluate the influence of temporal artery biopsy (TAB) techniques on establishing a diagnosis of giant cell arteritis (GCA).

Methods. A retrospective review of 141 TAB pathology records from 1996 to 2002 was conducted. Histopathology slides on 136 TAB were reviewed by a single, independent, blinded pathologist.

Results. The population included 101 (71.6%) women, mean age 75.8 years (range 45–92), and 40 men, mean age 73.9 years (range 47–90). The mean length of a TAB sample after formalin fixation was 1.76 cm (range 0.1–5.3). Surgeons performing the TAB represented 6 disciplines. Ophthalmologists had the largest volume, at 78 biopsies (55.3%), and the longest segments of artery, with a mean length of 2.37 cm (range 0.4–5.3) (p < 0.001). Comparison of biopsy interpretation provided a kappa coefficient of 0.8 (95% CI 0.69, 0.91). The 38 (27%) positive biopsies had a mean length of 2.07 cm (SD 1.1), and the 98 negative biopsies a mean length of 1.69 cm (SD 1.04) (p = 0.058). Biopsies < 1.0 cm length (n = 35, 25.7%) were less likely to be positive than those ≥ 1.0 cm (p = 0.037). No significant differences in surgical discipline, hospital site, number of slides, or cross-sections/cm artery were found between the positive and negative biopsies.

Conclusion. Biopsy specimens reported positive for GCA tended to be longer than those reported as negative. A "threshold" size of 1.0 cm is associated with increased diagnostic yield. Lack of standardization of biopsy harvesting and processing techniques may contribute to variable sensitivity of TAB. (J Rheumatol 2005;32:1279-82)

Key Indexing Terms:

TEMPORAL ARTERITIS
GIANT CELL ARTERITIS
BIOPSY
SENSITIVITY


From the Division of Rheumatology, Department of Medicine, and the Department of Internal Medicine, University of Saskatchewan, Saskatoon, Saskatchewan; and the Department of Pathology, University of Alberta, Edmonton, Alberta, Canada.

R.M. Taylor-Gjevre, MD, FRCPC, Division of Rheumatology; M. Vo, MD; D. Shukla, MD, Department of Internal Medicine, University of Saskatchewan; L. Resch, MD, FRCPC, Department of Pathology, University of Alberta.

Address reprint requests to Dr. R.M. Taylor-Gjevre, Division of Rheumatology, Department of Medicine, Royal University Hospital, 103 Hospital Drive, Saskatoon, SK S7N 0W8, Canada.

Accepted for publication February 21, 2005.




Return to July 2005 Table of Contents



© 2005. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.